TROG 15.01 SPARK Stereotactic Prostate Adaptive Radiotherapy utilising Kilovoltage intrafraction monitoring (SPARK)

Dataset Contains: Changes in dosimetric coverage of the prostate and normal healthy structures with KIM, Patient treatment outcomes determined by assessing:, Biochemical-clinical failure (BCF), Acute and late toxicity grade 3 or higher (using CTCAE version 4), Patient-reported outcomes one and two years after treatment, patient and radiation therapist perception of KIM, and give guidelines on how the system could be improved, improvement in the overall beam-target accuracy., QOL data: (EPIC)-26 (Baseline, 2 weeks post RT, 6 weeks post RT, 12 months post RT, 36 months post RT), Imaging Data: Cone Beam Computed Tomorgraphy (CBCT) scan, Approx Time of data collection: 2016-2020 Radiotherapy Quality Assurance, 48 participants RT Plan, RT delivery and Imaging documentation, plus KIM data and RapidPlan models/RTQA feedback (DICOM format), 5 participants Benchmarking datasets